Volatility & Risk Summit Midstream has a beta of 2.37, indicating that its stock price is 137% more volatile than the S&P 500. Comparatively, Summit Midstream’s competitors have a beta of 1.74, ...

ShankerValleau Wealth Advisors Inc. acquired a new position in shares of Vanguard Core Bond ETF (NASDAQ:VCRB – Free Report) ...

CAE (TSE:CAE – Get Free Report) (NYSE:CAE) was downgraded by equities researchers at TD Securities from a “buy” rating to a ...

Equities research analysts at StockNews.com started coverage on shares of EMCORE (NASDAQ:EMKR – Get Free Report) in a note ...

Analysts at StockNews.com initiated coverage on shares of Birks Group (NYSE:BGI – Get Free Report) in a note issued to investors on Sunday. The firm set a “sell” rating on the stock. Birks Group Stock ...

Equities researchers at StockNews.com initiated coverage on shares of Firsthand Technology Value Fund (NASDAQ:SVVC – Get Free Report) in a research report issued to clients and investors on Sunday.

Analysts at StockNews.com started coverage on shares of Remark (NASDAQ:MARK – Get Free Report) in a report released on Sunday. The brokerage set a “sell” rating on the information services provider’s ...

Equities researchers at StockNews.com started coverage on shares of Salem Media Group (NASDAQ:SALM – Get Free Report) in a research note issued to investors on Sunday. The firm set a “hold” rating on ...

Stock analysts at StockNews.com assumed coverage on shares of Cytosorbents (NASDAQ:CTSO – Get Free Report) in a research report issued to clients and investors on Sunday. The brokerage set a “hold” ...

StockNews.com assumed coverage on shares of ATA Creativity Global (NASDAQ:AACG – Get Free Report) in a research note issued on Sunday. The brokerage set a “sell” rating on the stock. ATA Creativity ...

Equities researchers at StockNews.com initiated coverage on shares of Great Ajax (NYSE:AJX – Get Free Report) in a report released on Sunday. The firm set a “sell” rating on the real estate investment ...

StockNews.com cut shares of Oramed Pharmaceuticals (NASDAQ:ORMP – Free Report) from a hold rating to a sell rating in a research report report published on Saturday. Separately, HC Wainwright ...